LRB-2422/1
JKS:klm
2023 - 2024 LEGISLATURE
2023 ASSEMBLY JOINT RESOLUTIO N 74
September 19, 2023 - Introduced by Representatives SUBECK, ROZAR, C. ANDERSON,
J. ANDERSON, ANDRACA, BARE, BINSFELD, CABRERA, CLANCY, CONSIDINE,
DITTRICH, DRAKE, EMERSON, HAYWOOD, JACOBSON, JOERS, S. JOHNSON, MADISON,
MAGNAFICI, MELOTIK, MOORE OMOKUNDE, MURPHY, MURSAU, O'CONNOR,
OHNSTAD, ORTIZ-VELEZ, PALMERI, RATCLIFF, SHANKLAND, SINICKI, SNODGRASS,
STUBBS, VINING and KITCHENS, cosponsored by Senators ROYS, BALLWEG,
CABRAL-GUEVARA, CARPENTER, HESSELBEIN, L. JOHNSON, LARSON, PFAFF,
SPREITZER, TAYLOR and WIRCH. Referred to Committee on Rules.
***AUTHORS SUBJECT TO CHANGE***
Relating to: designating September 2023 and September 2024 as Ovarian Cancer
Awareness Month.
Whereas, ovarian cancer is the deadliest of all gynecologic cancers and is most
common in postmenopausal women; and
Whereas, ovarian cancer ranks 17th in rates of new cancer cases among women
in the United States, but ranks sixth among cancer deaths for women, and is the
leading cause of death from cancer of the female reproductive system; and
Whereas, ovarian cancer accounts for 2.1 percent of all new cancer cases for
women, but 4.6 percent of all cancer deaths among women; and
Whereas, every woman is at risk for ovarian cancer regardless of age, heritage,
or medical history, and women with a family history of ovarian cancer and other
genetic factors are at an even higher risk; and
Whereas, approximately 230,000 women in the United States are living with
ovarian cancer; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14 - 2 -
LRB-2422/1
JKS:klm
2023 - 2024 Legislature
Whereas, the incidence of ovarian cancer in Wisconsin is slightly higher than
the national average; and
Whereas, only half of women diagnosed with ovarian cancer survive beyond five
years; and
Whereas, ovarian cancer may not cause early symptoms, and therefore its
diagnosis often does not occur until the disease has reached an advanced stage, at
which point the cancer may spread to other parts of the body; and
Whereas, the five-year survival rate for Stage 1 ovarian cancer is more than
90 percent, but the five year-survival rate for late-stage ovarian cancer is below 30
percent, and only 17 percent of ovarian cancers are diagnosed at Stage 1; and
Whereas, while a mammogram can detect breast cancer and a pap smear can
detect cervical cancer, there is no reliable early detection test for ovarian cancer; and
Whereas, additional ovarian cancer research and clinical trials are urgently
needed to develop prevention strategies, early detection tools, and better therapies,
in hopes of eventually finding a cure; and
Whereas, awareness and education are crucial, and women's lives will be saved
through public awareness about ovarian cancer and its risk factors, signs, and
symptoms; now, therefore, be it
Resolved by the assembly, the senate concurring, That the legislature
proclaims September 2023 and September 2024 to be Ovarian Cancer Awareness
Month in Wisconsin.
(END)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22